(Q42930467)

https://api.crossref.org/works/10.1128/AAC.23.2.284

11 November 2017

Norfloxacin disposition after sequentially increasing oral doses (English)

1 reference

31 August 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.23.2.284

31 August 2023

author name string

B. N. Swanson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220672

31 August 2023

V. K. Boppana

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220672

31 August 2023

P. H. Vlasses

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220672

31 August 2023

H. H. Rotmensch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220672

31 August 2023

R. K. Ferguson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220672

31 August 2023

language of work or name

English

0 references

publication date

1 February 1983

1 reference

PMCID

186038

full work available at URL

11 November 2017

https://europepmc.org/articles/PMC186038

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220672

https://europepmc.org/articles/PMC186038?pdf=render

31 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6220672

https://journals.asm.org/doi/pdf/10.1128/AAC.23.2.284

31 August 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.23.2.284

Antimicrobial Agents and Chemotherapy

31 August 2023

published in

1 reference

11 November 2017

23

1 reference

11 November 2017

284-288

1 reference

11 November 2017

2

1 reference

Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections

11 November 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=186038

In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa

27 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=186038

27 May 2018

Identifiers

DOI

10.1128/AAC.23.2.284

1 reference

11 November 2017

1 reference

11 November 2017

1 reference

PMCID

186038